PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Biochemistry and Microbiology, Zoonosis Science Center, Uppsala University, Uppsala, Sweden.\', \'Department of Microbiology and Tumour and Cell Biology (MTC), Karolinska Institute, Solna, Sweden.\', \'Department of Medical Sciences, Section of Clinical Physiology, Uppsala University, Uppsala, Sweden.\', \'Department of Medical Sciences, Zoonosis Science Center, Uppsala University, Uppsala, Sweden.\', \'Department of Medical Sciences, Section of Clinical Microbiology, Uppsala University, Uppsala, Sweden.\', \'Department of Medical Biochemistry and Microbiology, Zoonosis Science Center, Uppsala University, Uppsala, Sweden. Electronic address: ake.lundkvist@imbim.uu.se.\']
?:citedBy
  • -1
?:creator
?:doi
  • S2213-2317(20)30939-310.1016/j.redox.2020.101734
?:doi
?:hasPublicationType
?:journal
  • Redox biology
is ?:pmid of
?:pmid
?:pmid
  • 33007504
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.203
?:rankingScore_hIndex
  • 46
is ?:relation_isRelatedTo_publication of
?:title
  • Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all